Association Between Early Plasma Transfusion Burden and Mortality and Infection-Associated Organ Dysfunction in Severe Trauma Patients: A Single-Center Retrospective Exploratory Study
This single-center retrospective exploratory study of 100 severe trauma patients suggests a preliminary association between early 24-hour plasma transfusion volume and increased 30-day mortality risk, while finding no significant link between transfusion burden or injury severity and early infection-associated organ dysfunction, though the small sample size necessitates validation in larger prospective trials.
Original paper licensed under CC BY 4.0 (https://creativecommons.org/licenses/by/4.0/). This is an AI-generated explanation of the paper below. It is not written or endorsed by the authors. For technical accuracy, refer to the original paper. Read full disclaimer
When a person suffers a severe accident, the body's immediate reaction is a desperate, chaotic struggle to survive. Blood loss, tissue damage, and shock trigger a cascade of biological events that can shut down vital organs within hours. In the critical first day after such an injury, doctors focus on stopping the bleeding and replacing lost blood to keep the patient alive. This is where blood transfusions become a lifeline. However, medical science has long grappled with a difficult question: does the very treatment meant to save a life—the infusion of donor blood—sometimes carry hidden risks? Specifically, could the volume of blood given early on influence whether a patient survives the initial trauma or later develops a dangerous infection that attacks their organs? Understanding this balance is vital because trauma care has improved dramatically, yet hospital-acquired infections remain a leading cause of death and suffering for those who survive the initial crash.
Researchers at Zhoushan Hospital in Zhejiang Province set out to explore this complex relationship in a specific group of patients. They looked back at the records of one hundred individuals who had suffered severe trauma in 2025. These were not minor injuries; every patient had a high injury score, required admission to an intensive care unit, and needed either a breathing tube or emergency surgery to stop bleeding. The team focused on two main outcomes: whether the patient died within thirty days of admission, and whether they developed organ dysfunction linked to an infection within the first ten days. To make sense of the data, the researchers had to navigate a tricky problem. Patients who receive large amounts of blood usually have more severe injuries to begin with. It is like trying to tell if a car crash was bad because the car was hit hard, or because the driver was speeding; the two factors are deeply intertwined. The researchers also had to be careful not to confuse organ failure caused by the initial trauma with failure caused by a new infection, so they used a specific method to identify only those cases where an infection clearly drove the organ damage.
The study found that the volume of plasma, a liquid component of blood, given in the first twenty-four hours was linked to the risk of death. When the researchers analyzed the data, they observed that patients who received more plasma were more likely to die within thirty days. This association was noted after a minimal adjustment for injury severity, but the researchers emphasize that due to the small number of events, the models had insufficient statistical power. Therefore, these results should not be interpreted as definitive independent effects proving that the transfusion itself caused the deaths. The story was different when looking at infections. The researchers did not find a clear link between the amount of plasma given and the development of infection-related organ failure in the first ten days. In fact, the data suggested that the severity of the injury itself was a stronger predictor of whether a patient would survive the initial trauma, while the later development of infection seemed to depend on other factors, such as how long a patient needed a breathing tube.
It is important to understand the limits of these findings. The study involved a relatively small number of patients, with only thirteen deaths and twenty cases of infection-related organ failure. Because the number of events was so low, the statistical results are best viewed as early hints rather than final proof. The researchers explicitly state that their analysis cannot confirm that the blood transfusion itself caused the deaths, nor can it prove that the transfusion had no effect on infections. The small size of the group means the results could shift with more data. The team also noted that the patients they studied were a very specific, high-risk group who required intensive life support, so these results might not apply to all trauma patients.
Despite these limitations, the patterns observed offer a valuable direction for future inquiry. The data suggests that in the most critical phase of severe trauma, the sheer volume of plasma transfused might reflect the depth of the patient's physiological crisis, such as severe blood clotting problems or shock, which are the true drivers of early death. Meanwhile, the development of infection-related organ failure appears to be a separate challenge, potentially more influenced by the duration of invasive procedures and the body's prolonged vulnerability after the initial injury. The researchers conclude that while early plasma transfusion shows a numerical association with mortality risk in their small group, it does not appear to independently drive infection-related organ failure in the first ten days. These findings are not a call to change current medical practices, which prioritize stopping bleeding to save lives, but rather a signal that larger, more detailed studies are needed to fully untangle how blood transfusions, injury severity, and infection risks interact in the complex journey of trauma recovery.
Drowning in papers in your field?
Get daily digests of the most novel papers matching your research keywords — with technical summaries, in your language.